What Pharmacies Are Doing to Mitigate Shortages Due to COVID-19
Plus, ASHP comments on the latest drug shortage.
FDA OKs OTC Ibuprofen, Acetaminophen Combination Product
Advil Dual Action, an ibuprofen and acetaminophen fixed-dose combination, has been approved as an OTC product for pain relief.
Using Budgets to Increase Cash Flow for Your Pharmacy
Boost your financial IQ with these tips on how to manage your budget and increase cash flow.
The Apothecary Shoppe: An Inner-City Success Story
Kevin DeMass, RPh, is the owner and leader of a talented team of professionals that encounters a wide variety of patients, ailments, and medications.
Why Does the Varicella Zoster Virus Reactivate as Shingles?
Vaccination is first line of defense.
Report Shows Newer DAA Therapy Highly Effective for HCV, Recommends Universal Screening
A new systematic review demonstrates efficacy of direct-acting antiviral therapies and supports a recommendation for universal screening of hepatitis C virus.
COVID-19 Update: FDA Confirms First Drug Shortage, Other Supply Shortages Continue
The FDA announced the first drug shortage due to COVID-19, and pharmacies are having challenges keeping face masks and hand sanitizers stocked.
FDA OKs First Generic Version of Daraprim
Pyrimethamine (Daraprim) tablets are used to treat toxoplasmosis.
Re-exposure to Chickenpox Boosts Immunity to Shingles
British study supports exogenous boosting theory.
FDA OKs Fast-Acting Orally Disintegrating Tablet for Acute Migraine Treatment
Rimegepant (Nurtec ODT, Biohaven),a fast-acting orally disintegrating tablet, delivers quick and sustained efficacy for patients with migraine.
Pharmacy Groups Express Concerns About Health Care Megamergers
In new comments to the US government, several pharmacy groups say that mergers of major companies have had significant anticompetitive effects without improving the cost and quality of health care.
Investigational Drug May Reduce Symptoms in Refractory GERD
A new study tested the investigational drug in combination with proton pump inhibitors for patients with gastroesophageal reflux disease.
CDC: New Diabetes Cases Down Among Adults, But On the Rise in Youth
The CDC’s 2020 National Diabetes Statistics Report outlines the current state of the disease.
Benefits of Hypertension Treatments Largely Similar Across Drug Classes
The differences between antihypertension medication classes were generally small and nuanced in terms of their effect on reducing cardiovascular risks.
Pharmacists Concerned About Shortages in Wake of Coronavirus
Separately, a pharmacy association executive urges Americans to receive the flu vaccine.
Informed Pharmacists Can Reduce Barriers to Naloxone in Rural Communities
Regardless of naloxone availability, rural pharmacies can serve as an educational resource for individuals seeking access to the medication.
Analysis: Apixaban Associated with Lower Risks Than Warfarin
A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.
FDA OKs New Non-Statin, LDL-C Lowering Treatment
Bempedoic acid (Nexletol, Esperion) is a new lipid-lowering therapy option for patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease.
Pharmacist Groups Support Supreme Court PBM Case
Several pharmacy groups said they will file a brief in the Supreme Court case, Rutledge v. the Pharmaceutical Care Management Association.
Mobile Patient Portal Access Can Improve Diabetes Care
Patient access to portal self-management tools through mobile devices may help significantly improve diabetes care.
FDA Approves First IV Treatment for Migraine Prevention
Eptinezumab-jjmr (Vyepti, Lundbeck) decreased mean monthly migraine days in adult patients in 2 phase 3 clinical trials.
Top 5 Things to Know About COVID-19
FDA responds to shortages, plus other important updates.
Patients At Highest Risk of Overdose at Beginning, After End of Methadone Treatment
Patients receiving methadone treatment are at most risk of overdosing during the first 4 weeks of treatment initiation and following the end of treatment.
Express Scripts Report: Top Drug Classes Driving Spending Growth
Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.
Real-World Data Show Clinical Benefits of FreeStyle Libre System in Diabetes
The FreeStyle Libre system decreased HbA1c, increased time in glucose range, and reduced diabetes complications.
New Options for Sickle Cell Disease
Despite sickle cell disease's (SCD) lower profile, 3 new SCD drugs were approved in the last 3 years, with 2 approvals occurring in late 2019
Adolescents, Young Adults with HIV Have Lower Viral Suppression Rates
Quicker referral time to youth-friendly care services could help younger patients with HIV achieve better outcomes.
Harmons Pharmacies Are Special
Greg Jones, RPh, MBA, director of pharmacy services and his team are doing some amazing things in pharmacy.
New Primary Care Model Leveraging Pharmacists Can Curb Health Costs
NACDS praised the new Kaiser Permanente model, which utilizes pharmacists and pharmacy technicians to save significant health care costs.
Pharmacists: Trusted Professionals On the Frontlines of Patient Care
